Global Opioid Induced Constipation (OIC) Drugs Market Research Report 2021

Published: January 2021

No. of Pages: 121

Price:

Single User License: US $ 2900 US $ 2320
Corporate User License: US $ 5800 US $ 4640

Report Description
Table of Contents

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
- Lubiprostone
- Methyl Naltrexone Bromide
- Naldemedine
- Alvimopan
- Other

Segment by Application
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies

By Region
- North America
- - U.S.
- - Canada
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- Asia-Pacific
- - China
- - Japan
- - South Korea
- - India
- - Australia
- - Taiwan
- - Indonesia
- - Thailand
- - Malaysia
- - Philippines
- - Vietnam
- Latin America
- - Mexico
- - Brazil
- - Argentina
- Middle East & Africa
- - Turkey
- - Saudi Arabia
- - U.A.E

By Company
- Ironwood Pharmaceuticals Inc
- Daiichi Sankyo Co Ltd
- Pfizer
- Progenics Pharmaceuticals Inc
- Shionogi & Co., Ltd
- Allergan Plc
- Nektar Therapeutics
- Purdue Pharma
- S.L.A. Pharma AG
- Mundipharma International Limited
- Ono Pharmaceutical Co., Ltd
- Takeda Pharmaceutical Company Limited
- Theravance Biopharma Inc
- Bausch Health
- Cosmo Pharmaceuticals SA
- Daewoong Pharmaceutical
- C.B. Fleet Company
- Sucampo Pharmaceuticals

Table of Contents

1 Opioid Induced Constipation (OIC) Drugs Market Overview
1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Opioid Induced Constipation (OIC) Drugs Segment by Type
1.2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Lubiprostone
1.2.3 Methyl Naltrexone Bromide
1.2.4 Naldemedine
1.2.5 Alvimopan
1.2.6 Other
1.3 Opioid Induced Constipation (OIC) Drugs Segment by Application
1.3.1 Opioid Induced Constipation (OIC) Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Opioid Induced Constipation (OIC) Drugs Market Size Estimates and Forecasts
1.4.1 Global Opioid Induced Constipation (OIC) Drugs Revenue 2016-2027
1.4.2 Global Opioid Induced Constipation (OIC) Drugs Sales 2016-2027
1.4.3 Opioid Induced Constipation (OIC) Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 Opioid Induced Constipation (OIC) Drugs Market Competition by Manufacturers
2.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Opioid Induced Constipation (OIC) Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Sites, Area Served, Product Type
2.5 Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
2.5.1 Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Opioid Induced Constipation (OIC) Drugs Players Market Share by Revenue
2.5.3 Global Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario by Region
3.1 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Opioid Induced Constipation (OIC) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.3.1 North America Opioid Induced Constipation (OIC) Drugs Sales by Country
3.3.2 North America Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.4.1 Europe Opioid Induced Constipation (OIC) Drugs Sales by Country
3.4.2 Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region
3.5.2 Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.6.1 Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country
3.6.2 Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country
3.7.2 Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Opioid Induced Constipation (OIC) Drugs Historic Market Analysis by Type
4.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2016-2021)
4.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Type (2016-2021)
4.3 Global Opioid Induced Constipation (OIC) Drugs Price by Type (2016-2021)

5 Global Opioid Induced Constipation (OIC) Drugs Historic Market Analysis by Application
5.1 Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2016-2021)
5.2 Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Application (2016-2021)
5.3 Global Opioid Induced Constipation (OIC) Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Ironwood Pharmaceuticals Inc
6.1.1 Ironwood Pharmaceuticals Inc Corporation Information
6.1.2 Ironwood Pharmaceuticals Inc Description and Business Overview
6.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Ironwood Pharmaceuticals Inc Product Portfolio
6.1.5 Ironwood Pharmaceuticals Inc Recent Developments/Updates
6.2 Daiichi Sankyo Co Ltd
6.2.1 Daiichi Sankyo Co Ltd Corporation Information
6.2.2 Daiichi Sankyo Co Ltd Description and Business Overview
6.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Daiichi Sankyo Co Ltd Product Portfolio
6.2.5 Daiichi Sankyo Co Ltd Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Progenics Pharmaceuticals Inc
6.4.1 Progenics Pharmaceuticals Inc Corporation Information
6.4.2 Progenics Pharmaceuticals Inc Description and Business Overview
6.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Progenics Pharmaceuticals Inc Product Portfolio
6.4.5 Progenics Pharmaceuticals Inc Recent Developments/Updates
6.5 Shionogi & Co., Ltd
6.5.1 Shionogi & Co., Ltd Corporation Information
6.5.2 Shionogi & Co., Ltd Description and Business Overview
6.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Shionogi & Co., Ltd Product Portfolio
6.5.5 Shionogi & Co., Ltd Recent Developments/Updates
6.6 Allergan Plc
6.6.1 Allergan Plc Corporation Information
6.6.2 Allergan Plc Description and Business Overview
6.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Allergan Plc Product Portfolio
6.6.5 Allergan Plc Recent Developments/Updates
6.7 Nektar Therapeutics
6.6.1 Nektar Therapeutics Corporation Information
6.6.2 Nektar Therapeutics Description and Business Overview
6.6.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Nektar Therapeutics Product Portfolio
6.7.5 Nektar Therapeutics Recent Developments/Updates
6.8 Purdue Pharma
6.8.1 Purdue Pharma Corporation Information
6.8.2 Purdue Pharma Description and Business Overview
6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Purdue Pharma Product Portfolio
6.8.5 Purdue Pharma Recent Developments/Updates
6.9 S.L.A. Pharma AG
6.9.1 S.L.A. Pharma AG Corporation Information
6.9.2 S.L.A. Pharma AG Description and Business Overview
6.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 S.L.A. Pharma AG Product Portfolio
6.9.5 S.L.A. Pharma AG Recent Developments/Updates
6.10 Mundipharma International Limited
6.10.1 Mundipharma International Limited Corporation Information
6.10.2 Mundipharma International Limited Description and Business Overview
6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Mundipharma International Limited Product Portfolio
6.10.5 Mundipharma International Limited Recent Developments/Updates
6.11 Ono Pharmaceutical Co., Ltd
6.11.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.11.2 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.11.3 Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Ono Pharmaceutical Co., Ltd Product Portfolio
6.11.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.12 Takeda Pharmaceutical Company Limited
6.12.1 Takeda Pharmaceutical Company Limited Corporation Information
6.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Takeda Pharmaceutical Company Limited Product Portfolio
6.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
6.13 Theravance Biopharma Inc
6.13.1 Theravance Biopharma Inc Corporation Information
6.13.2 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.13.3 Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Theravance Biopharma Inc Product Portfolio
6.13.5 Theravance Biopharma Inc Recent Developments/Updates
6.14 Bausch Health
6.14.1 Bausch Health Corporation Information
6.14.2 Bausch Health Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.14.3 Bausch Health Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Bausch Health Product Portfolio
6.14.5 Bausch Health Recent Developments/Updates
6.15 Cosmo Pharmaceuticals SA
6.15.1 Cosmo Pharmaceuticals SA Corporation Information
6.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Cosmo Pharmaceuticals SA Product Portfolio
6.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates
6.16 Daewoong Pharmaceutical
6.16.1 Daewoong Pharmaceutical Corporation Information
6.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Daewoong Pharmaceutical Product Portfolio
6.16.5 Daewoong Pharmaceutical Recent Developments/Updates
6.17 C.B. Fleet Company
6.17.1 C.B. Fleet Company Corporation Information
6.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 C.B. Fleet Company Product Portfolio
6.17.5 C.B. Fleet Company Recent Developments/Updates
6.18 Sucampo Pharmaceuticals
6.18.1 Sucampo Pharmaceuticals Corporation Information
6.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Description and Business Overview
6.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Sucampo Pharmaceuticals Product Portfolio
6.18.5 Sucampo Pharmaceuticals Recent Developments/Updates

7 Opioid Induced Constipation (OIC) Drugs Manufacturing Cost Analysis
7.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
7.4 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Opioid Induced Constipation (OIC) Drugs Distributors List
8.3 Opioid Induced Constipation (OIC) Drugs Customers

9 Opioid Induced Constipation (OIC) Drugs Market Dynamics
9.1 Opioid Induced Constipation (OIC) Drugs Industry Trends
9.2 Opioid Induced Constipation (OIC) Drugs Growth Drivers
9.3 Opioid Induced Constipation (OIC) Drugs Market Challenges
9.4 Opioid Induced Constipation (OIC) Drugs Market Restraints

10 Global Market Forecast
10.1 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs by Type (2022-2027)
10.2 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs by Application (2022-2027)
10.3 Opioid Induced Constipation (OIC) Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Opioid Induced Constipation (OIC) Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Opioid Induced Constipation (OIC) Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables
Table 1. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Opioid Induced Constipation (OIC) Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Opioid Induced Constipation (OIC) Drugs Covered in This Study
Table 5. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers (2016-2021)
Table 7. Global Opioid Induced Constipation (OIC) Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Opioid Induced Constipation (OIC) Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Opioid Induced Constipation (OIC) Drugs Product Type
Table 12. Global Opioid Induced Constipation (OIC) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Opioid Induced Constipation (OIC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid Induced Constipation (OIC) Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Opioid Induced Constipation (OIC) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2016-2021)
Table 17. Global Opioid Induced Constipation (OIC) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Opioid Induced Constipation (OIC) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2016-2021)
Table 20. North America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe Opioid Induced Constipation (OIC) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe Opioid Induced Constipation (OIC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America Opioid Induced Constipation (OIC) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America Opioid Induced Constipation (OIC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2016-2021)
Table 39. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type (2016-2021)
Table 40. Global Opioid Induced Constipation (OIC) Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2016-2021)
Table 42. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2016-2021)
Table 44. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2016-2021)
Table 45. Global Opioid Induced Constipation (OIC) Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Application (2016-2021)
Table 47. Global Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Application (2016-2021)
Table 48. Ironwood Pharmaceuticals Inc Corporation Information
Table 49. Ironwood Pharmaceuticals Inc Description and Business Overview
Table 50. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
Table 52. Ironwood Pharmaceuticals Inc Recent Developments/Updates
Table 53. Daiichi Sankyo Co Ltd Corporation Information
Table 54. Daiichi Sankyo Co Ltd Description and Business Overview
Table 55. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 57. Daiichi Sankyo Co Ltd Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Pfizer Opioid Induced Constipation (OIC) Drugs Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Progenics Pharmaceuticals Inc Corporation Information
Table 64. Progenics Pharmaceuticals Inc Description and Business Overview
Table 65. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Product
Table 67. Progenics Pharmaceuticals Inc Recent Developments/Updates
Table 68. Shionogi & Co., Ltd Corporation Information
Table 69. Shionogi & Co., Ltd Description and Business Overview
Table 70. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 72. Shionogi & Co., Ltd Recent Developments/Updates
Table 73. Allergan Plc Corporation Information
Table 74. Allergan Plc Description and Business Overview
Table 75. Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Allergan Plc Opioid Induced Constipation (OIC) Drugs Product
Table 77. Allergan Plc Recent Developments/Updates
Table 78. Nektar Therapeutics Corporation Information
Table 79. Nektar Therapeutics Description and Business Overview
Table 80. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Product
Table 82. Nektar Therapeutics Recent Developments/Updates
Table 83. Purdue Pharma Corporation Information
Table 84. Purdue Pharma Description and Business Overview
Table 85. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Purdue Pharma Opioid Induced Constipation (OIC) Drugs Product
Table 87. Purdue Pharma Recent Developments/Updates
Table 88. S.L.A. Pharma AG Corporation Information
Table 89. S.L.A. Pharma AG Description and Business Overview
Table 90. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Product
Table 92. S.L.A. Pharma AG Recent Developments/Updates
Table 93. Mundipharma International Limited Corporation Information
Table 94. Mundipharma International Limited Description and Business Overview
Table 95. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 96. Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Product
Table 97. Mundipharma International Limited Recent Developments/Updates
Table 98. Ono Pharmaceutical Co., Ltd Corporation Information
Table 99. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 100. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 101. Ono Pharmaceutical Co., Ltd Opioid Induced Constipation (OIC) Drugs Product
Table 102. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 103. Takeda Pharmaceutical Company Limited Corporation Information
Table 104. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 105. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 106. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drugs Product
Table 107. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 108. Theravance Biopharma Inc Corporation Information
Table 109. Theravance Biopharma Inc Description and Business Overview
Table 110. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 111. Theravance Biopharma Inc Opioid Induced Constipation (OIC) Drugs Product
Table 112. Theravance Biopharma Inc Recent Developments/Updates
Table 113. Bausch Health Corporation Information
Table 114. Bausch Health Description and Business Overview
Table 115. Bausch Health Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 116. Bausch Health Opioid Induced Constipation (OIC) Drugs Product
Table 117. Bausch Health Recent Developments/Updates
Table 118. Cosmo Pharmaceuticals SA Corporation Information
Table 119. Cosmo Pharmaceuticals SA Description and Business Overview
Table 120. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 121. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drugs Product
Table 122. Cosmo Pharmaceuticals SA Recent Developments/Updates
Table 123. Daewoong Pharmaceutical Corporation Information
Table 124. Daewoong Pharmaceutical Description and Business Overview
Table 125. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 126. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drugs Product
Table 127. Daewoong Pharmaceutical Recent Developments/Updates
Table 128. C.B. Fleet Company Corporation Information
Table 129. C.B. Fleet Company Description and Business Overview
Table 130. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 131. C.B. Fleet Company Opioid Induced Constipation (OIC) Drugs Product
Table 132. C.B. Fleet Company Recent Developments/Updates
Table 133. Sucampo Pharmaceuticals Corporation Information
Table 134. Sucampo Pharmaceuticals Description and Business Overview
Table 135. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 136. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drugs Product
Table 137. Sucampo Pharmaceuticals Recent Developments/Updates
Table 138. Production Base and Market Concentration Rate of Raw Material
Table 139. Key Suppliers of Raw Materials
Table 140. Opioid Induced Constipation (OIC) Drugs Distributors List
Table 141. Opioid Induced Constipation (OIC) Drugs Customers List
Table 142. Opioid Induced Constipation (OIC) Drugs Market Trends
Table 143. Opioid Induced Constipation (OIC) Drugs Growth Drivers
Table 144. Opioid Induced Constipation (OIC) Drugs Market Restraints
Table 145. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Type (2022-2027) & (K Pcs)
Table 146. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 147. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 148. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 149. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Application (2022-2027) & (K Pcs)
Table 150. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 151. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 152. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 153. Global Opioid Induced Constipation (OIC) Drugs Sales Forecast by Region (2022-2027) & (K Pcs)
Table 154. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 155. Global Opioid Induced Constipation (OIC) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 156. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure 2. Global Opioid Induced Constipation (OIC) Drugs Market Share by Type in 2020 & 2027
Figure 3. Lubiprostone Product Picture
Figure 4. Methyl Naltrexone Bromide Product Picture
Figure 5. Naldemedine Product Picture
Figure 6. Alvimopan Product Picture
Figure 7. Other Product Picture
Figure 8. Global Opioid Induced Constipation (OIC) Drugs Market Share by Application in 2020 & 2027
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Opioid Induced Constipation (OIC) Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Opioid Induced Constipation (OIC) Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Opioid Induced Constipation (OIC) Drugs Sales 2016-2027 (K Pcs)
Figure 15. Global Opioid Induced Constipation (OIC) Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Opioid Induced Constipation (OIC) Drugs Sales Share by Manufacturers in 2020
Figure 17. Global Opioid Induced Constipation (OIC) Drugs Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drugs Players: Market Share by Revenue in 2020
Figure 19. Opioid Induced Constipation (OIC) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region (2016-2021)
Figure 21. Global Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2020
Figure 22. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2016-2021)
Figure 23. Global Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in 2020
Figure 24. U.S. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Opioid Induced Constipation (OIC) Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Opioid Induced Constipation (OIC) Drugs Revenue Gr

Write comment about above report:

Published By: QYResearch Group

Product Code: QYResearch Group1024510

Related Reports

Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Global Opioid-Induced Constipation (OIC) Treatment Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery Opioids are a class of medications that are regularly endorsed for their pain relieving, or pain-killing, properties it is chronic and non-cancer pain. A typical symptom connected with the utilization of these medications are that they decrease the g...
Global Opioid Induced Constipation (OIC) Drug Market Report 2020 - Market Size, Share, Price, Trend and Forecast The global market size of Opioid Induced Constipation (OIC) Drug is $XX million in 2019 with XX CAGR from 2015 to 2019, and it is expected to reach $XX million by the end of 2025 with a CAGR of XX% from 2020 to 2025. Global Opioid Indu...
Global Opioid Induced Constipation (OIC) Drugs Market Analysis 2016-2020 and Forecast 2021-2026 Snapshot The global Opioid Induced Constipation (OIC) Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins ...
Opioid Induced Constipation (OIC) Drugs Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 Opioid Induced Constipation (OIC) Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Opioid Induced Constipation (OIC) Drugs industry with a focus on the Chinese market. The...
Opioid-Induced Constipation (OIC) Treatment Market Insights 2019, Global and Chinese Analysis and Forecast to 2024 Opioid-Induced Constipation (OIC) Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Opioid-Induced Constipation (OIC) Treatment industry with a focus on the Chinese mar...
Global Opioid Induced Constipation (OIC) Drugs Market 2020, Production, Consumption, Revenue, by Major Companies In this report, XYZ-research offers a comprehensive analysis of key market trends in the global Opioid Induced Constipation (OIC) Drugs market. It also includes discussion on historical trends, current market status, competitive landscape, growth opp...
Global Opioid Induced Constipation (OIC) Drugs Market 2020, Market Size, Revenue, Growth Trend by Major Companies and Major Countries In this report, the study analysis was given on a worldwide scale, for instance, present and traditional Opioid Induced Constipation (OIC) Drugsgrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gi...
Global Opioid Induced Constipation (OIC) Drugs Market Analysis 2020, Sales, Revenue, Growth Trend, SWOT Analysis In this report, our team research the global Opioid Induced Constipation (OIC) Drugs market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market share...
Global Opioid Induced Constipation (OIC) Drugs Market Professional Survey Report 2020, Capacity, Sales, Major Companies and Regions In this report, our team offers a comprehensive analysis of Opioid Induced Constipation (OIC) Drugs market, SWOT analysis of the most prominent players in this landscape. Along with an industrial chain,market statistics in terms of revenue, sales, pr...
Asia-Pacific Opioid Induced Constipation (OIC) Drugs Market Analysis 2020 In this report, our team research theAsia-Pacific Opioid Induced Constipation (OIC) Drugs market by type, application, region and manufacturer 2014-2020 and forcast 2021-2026. For the region, type and application, the sales, revenue and their market ...

We are on:

Why ReportsnReports.com?

500,000 market research reports and growing.
Top Fortune 500 Organizations trust us for research data.
24/7 support on call as well as emails.
Your Details are safe with us.
Free support for your research requirements.
Report Delivery: Email
Delivery Time:
- Upto 24 hrs - working days
- Upto 48 hrs max - weekends and public holidays

Need Help?

Name *

Email *

Phone *

Country *

Subject *

Comments *